Sioux Falls, S.D.-based Avera Health has received more than $10 million in federal funding to improve rural cancer care services. The system will purchase a fixed PET/CT scanner for the Avera Cancer Institute in Yankton, S.D., and replace linear accelerators…
Oncology
Peoria, Ill.-based OSF HealthCare has tapped Robert McWilliams, MD, as deputy director of the OSF Cancer Institute. Dr. McWilliams’ appointment aligns with plans to expand the cancer institute’s facilities to include medical oncology, surgical oncology and research areas, as well…
Buffalo, N.Y.-based Roswell Park Comprehensive Cancer Center has received $3 million to support the expansion of its Community Outreach and Engagement Center. The funding will be used to develop a Health, Outreach and Prevention Excellence Center. Roswell Park will begin…
Access to comprehensive cancer care in the U.S. is as varied across state lines as cancer incidence and mortality. The geographic distribution of the nation’s most research-intensive organizations — National Cancer Institute-designated cancer centers — does not align neatly with…
The University of Cincinnati Cancer Center has expanded services with the addition of research laboratories, a wellness suite and a learning kitchen. The expansion brings research and integrative care under the same roof as clinical services, which have been in…
Advertisement
Chapel Hill, N.C.-based UNC Health will expand its radiation oncology program with the addition of proton therapy. The health system will install the proton therapy system at UNC Hospitals in Chapel Hill and integrate the treatment into existing oncology services,…
On July 1, members of Humana’s Medicare Advantage PPO and HMO plans will lose coverage for care received at Tampa, Fla.-based Moffitt Cancer Center. Humana terminated the coverage agreement for business reasons unrelated to care quality, according to a statement…
Johnson & Johnson will build a $1 billion cell therapy manufacturing facility in Montgomery County, Pa. The project will support more than 4,000 jobs during construction and more than 500 biomanufacturing jobs once the facility is fully operational, according to…
A team at Morgantown, W.Va.-based WVU Cancer Institute has become the first in the world to treat a patient with CD19-positive mixed phenotype acute leukemia with a subcutaneous formulation delivery for blinatumomab. The patient received the first dose Jan. 17…
With cancer care growing beyond hospital walls and more cancer patients surviving than ever before, health systems in the U.S. are doubling down on their oncology infrastructure commitments. “Cancer care can no longer be designed around treatment alone. We must…